• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于锰卟啉的疗法对氧化应激的氧化还原调节:电荷分布的影响

Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.

作者信息

Rebouças Júlio S, Spasojević Ivan, Tjahjono Daryono H, Richaud Arlette, Méndez Francisco, Benov Ludmil, Batinić-Haberle Ines

机构信息

Department of Radiation Oncology, Duke University Medical School, Durham, NC 27710, USA.

出版信息

Dalton Trans. 2008 Mar 7(9):1233-42. doi: 10.1039/b716517j. Epub 2008 Jan 7.

DOI:10.1039/b716517j
PMID:18283384
Abstract

We evaluate herein the impact of positive charge distribution on the in vitro and in vivo properties of Mn porphyrins as redox modulators possessing the same overall 5+ charge and of minimal stericity demand: Mn(III) meso-tetrakis(trimethylanilinium-4-yl)porphyrin (MnTTriMAP(5+)), Mn(III) meso-tetrakis(N,N'-dimethylpyrazolium-4-yl)porphyrin (MnTDM-4-PzP(5+)), Mn(III) meso-tetrakis(N,N'-dimethylimidazolium-2-yl)porphyrin (MnTDM-2-ImP(5+)), and the ortho and para methylpyridinium complexes Mn(III) meso-tetrakis(N-methylpyridinium-4-yl)porphyrin (MnTM-4-PyP(5+)) and Mn(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin (MnTM-2-PyP(5+)). Both Mn(III)/Mn(II) reduction potential and SOD activity within the series follow the order: MnTTriMAP(5+)<MnTDM-4-PzP(5+)<MnTM-4-PyP(5+)<MnTM-2-PyP(5+)<MnTDM-2-ImP(5+). The kinetic salt effect (KSE) on the catalytic rate constant for superoxide dismutation (k(cat)) indicates that the electrostatic contribution to the O(2)*(-) dismutation is the greatest with MnTM-2-PyP(5+) and follows the order: MnTM-4-PyP(5+)<MnTDM-4-PzP(5+) approximately MnTDM-2-ImP(5+)<MnTM-2-PyP(5+). The KSE observed on k(cat) suggests that the charges are relatively confined within specific regions of the aryl rings. Whereas the charges in imidazolium, pyrazolium, and MnTM-4-PyP(5+) compounds are distributed in-plane with the porphyrin ring, the charges of MnTM-2-PyP(5+) are either above or below the plane, which channels the negatively-charged superoxide toward the axial positions of the Mn porphyrin more efficiently, and leads to the highest KSE. This mimics the tunneling effect observed in the SOD enzymes themselves. The modulation of the reactivity of the Mn center by the electronic perturbations caused by the meso-aryl substituent could be explained by DFT calculation, whereby a correlation between the Mn(III)/Mn(II) reduction potential (and/or SOD activity) and meso-aryl fragment softness descriptors for nucleophilic (s(f)(+)) and radical (s(f)(o)) attacks was observed. MnTDM-4-PzP(5+) and MnTM-4-PyP(5+) did not protect SOD-deficient E. coli grown aerobically, which is in agreement with their low k(cat). MnTM-2-PyP(5+) and MnTDM-2-ImP(5+) have similar high k(cat), but MnTDM-2-ImP(5+) was significantly less protective to E. coli, probably due to its bulkier size, decreased cellular uptake, and/or observed toxicity. The placement of charges closer to the metal center and spatial charge localization increases both the in vitro and the in vivo SOD activity of the compound.

摘要

我们在此评估正电荷分布对锰卟啉作为氧化还原调节剂的体外和体内性质的影响,这些锰卟啉具有相同的 +5 总电荷且空间位阻需求最小:锰(III)中 - 四(三甲基苯胺 -4- 基)卟啉(MnTTriMAP(5+))、锰(III)中 - 四(N,N'- 二甲基吡唑 -4- 基)卟啉(MnTDM - 4 - PzP(5+))、锰(III)中 - 四(N,N'- 二甲基咪唑 -2- 基)卟啉(MnTDM - 2 - ImP(5+)),以及邻位和对位甲基吡啶鎓配合物锰(III)中 - 四(N - 甲基吡啶 -4- 基)卟啉(MnTM - 4 - PyP(5+))和锰(III)中 - 四(N - 甲基吡啶 -2- 基)卟啉(MnTM - 2 - PyP(5+))。该系列中锰(III)/锰(II)还原电位和超氧化物歧化酶(SOD)活性遵循以下顺序:MnTTriMAP(5+)<MnTDM - 4 - PzP(5+)<MnTM - 4 - PyP(5+)<MnTM - 2 - PyP(5+)<MnTDM - 2 - ImP(5+)。超氧化物歧化反应催化速率常数(k(cat))的动力学盐效应(KSE)表明,对 O(2)*(-) 歧化的静电贡献以 MnTM - 2 - PyP(5+) 最大,且遵循以下顺序:MnTM - 4 - PyP(5+)<MnTDM - 4 - PzP(5+)≈MnTDM - 2 - ImP(5+)<MnTM - 2 - PyP(5+)。在 k(cat) 上观察到的 KSE 表明电荷相对局限于芳环的特定区域内。咪唑鎓、吡唑鎓和 MnTM - 4 - PyP(5+) 化合物中的电荷与卟啉环共面分布,而 MnTM - 2 - PyP(5+) 的电荷在平面上方或下方,这更有效地将带负电荷的超氧化物导向锰卟啉的轴向位置,并导致最高的 KSE。这模拟了在 SOD 酶本身中观察到的隧道效应。中 - 芳基取代基引起的电子扰动对锰中心反应性的调节可以通过密度泛函理论(DFT)计算来解释,由此观察到锰(III)/锰(II)还原电位(和 / 或 SOD 活性)与亲核(s(f)(+))和自由基(s(f)(o))攻击的中 - 芳基片段软度描述符之间的相关性。MnTDM - 4 - PzP(5+) 和 MnTM - 4 - PyP(5+) 不能保护需氧生长的超氧化物歧化酶缺陷型大肠杆菌,这与其低 k(cat) 一致。MnTM - 2 - PyP(5+) 和 MnTDM - 2 - ImP(5+) 具有相似的高 k(cat),但 MnTDM - 2 - ImP(5+) 对大肠杆菌的保护作用明显较小,可能是由于其体积较大、细胞摄取减少和 / 或观察到的毒性。电荷更靠近金属中心的位置和空间电荷定位增加了化合物的体外和体内 SOD 活性。

相似文献

1
Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.基于锰卟啉的疗法对氧化应激的氧化还原调节:电荷分布的影响
Dalton Trans. 2008 Mar 7(9):1233-42. doi: 10.1039/b716517j. Epub 2008 Jan 7.
2
New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.新型高效超氧阴离子歧化催化剂。锰(III)邻甲氧基乙基吡啶基和二邻甲氧基乙基咪唑基卟啉。
Dalton Trans. 2004 Jun 7(11):1696-702. doi: 10.1039/b400818a. Epub 2004 May 5.
3
SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself.锰(II)β-八溴-内消旋四(N-甲基吡啶-3-基)卟啉的超氧化物歧化酶样活性与该酶本身的活性相当。
Arch Biochem Biophys. 2008 Sep 1;477(1):105-12. doi: 10.1016/j.abb.2008.04.032. Epub 2008 Apr 30.
4
Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.甲氧基衍生化烷基链可提高阳离子锰卟啉的体内疗效。间位 Mn(III) N-甲氧基烷基吡啶基卟啉的合成、表征、SOD 样活性及 SOD 缺陷型大肠杆菌研究。
Dalton Trans. 2011 Apr 28;40(16):4111-21. doi: 10.1039/c0dt01321h. Epub 2011 Mar 8.
5
Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.超氧化物歧化酶模拟物催化O2*- 歧化反应中的静电作用。MnIIITE-2-PyP5+与MnIIIBr8T-2-PyP+的比较
J Biol Chem. 2003 Feb 28;278(9):6831-7. doi: 10.1074/jbc.M211346200. Epub 2002 Dec 9.
6
Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.用于临床前机制研究/治疗目的的高效锰卟啉基超氧化物歧化酶模拟物和过氧亚硝酸盐清除剂的质量。
J Pharm Biomed Anal. 2008 Nov 4;48(3):1046-9. doi: 10.1016/j.jpba.2008.08.005. Epub 2008 Aug 14.
7
Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.静电在锰卟啉对氧化应激的氧化还原调节中的作用:通过替代机制保护超氧化物歧化酶缺陷型大肠杆菌,其中锰卟啉作为锰载体。
Free Radic Biol Med. 2008 Jul 15;45(2):201-10. doi: 10.1016/j.freeradbiomed.2008.04.009. Epub 2008 May 5.
8
Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.铁卟啉与锰卟啉水溶性阳离子金属配合物的配位差异要求导致其在水相氧化还原化学和生物学方面表现出显著不同。
Inorg Chem. 2013 May 20;52(10):5677-91. doi: 10.1021/ic3012519. Epub 2013 May 6.
9
Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.超氧化物歧化酶模拟物MnTE-2-PyP(5+)可改善大鼠直肠局部质子照射后的急慢性直肠炎。
Redox Biol. 2013 Oct 25;1(1):599-607. doi: 10.1016/j.redox.2013.10.002. eCollection 2013.
10
The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic.邻位效应使中-四(N-甲基吡啶-2-基)卟啉锰(III)成为一种强大且可能有用的超氧化物歧化酶模拟物。
J Biol Chem. 1998 Sep 18;273(38):24521-8. doi: 10.1074/jbc.273.38.24521.

引用本文的文献

1
Metal complexes as potential modulators of inflammatory and autoimmune responses.金属配合物作为炎症和自身免疫反应的潜在调节剂。
Chem Sci. 2015 Feb 2;6(2):871-884. doi: 10.1039/c4sc03094j. Epub 2014 Nov 7.
2
Simple biological systems for assessing the activity of superoxide dismutase mimics.用于评估超氧化物歧化酶模拟物活性的简单生物体系。
Antioxid Redox Signal. 2014 May 20;20(15):2416-36. doi: 10.1089/ars.2013.5576. Epub 2013 Oct 19.
3
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.
SOD 治疗学:对其结构-活性关系及其对细胞基于氧化还原的信号通路的影响的最新见解。
Antioxid Redox Signal. 2014 May 20;20(15):2372-415. doi: 10.1089/ars.2012.5147. Epub 2013 Oct 1.
4
Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.两种基于锰卟啉的 SOD 模拟物,MnTE-2-PyP5+ 和 MnTnHex-2-PyP5+ 的全面药代动力学研究和口服生物利用度。
Free Radic Biol Med. 2013 May;58:73-80. doi: 10.1016/j.freeradbiomed.2013.01.006. Epub 2013 Jan 15.
5
Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.基于锰卟啉的氧化还原调节剂的设计、作用机制、生物利用度和治疗效果。
Med Princ Pract. 2013;22(2):103-30. doi: 10.1159/000341715. Epub 2012 Oct 16.
6
Detailed mechanism of the autoxidation of N-hydroxyurea catalyzed by a superoxide dismutase mimic Mn(III) porphyrin: formation of the nitrosylated Mn(II) porphyrin as an intermediate.超氧化物歧化酶模拟物 Mn(III)卟啉催化 N-羟基脲自氧化的详细机制:作为中间产物的硝酰化 Mn(II)卟啉的形成。
Dalton Trans. 2012 Oct 14;41(38):11875-84. doi: 10.1039/c2dt31200j. Epub 2012 Aug 22.
7
Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).典型的基于锰卟啉的超氧化物歧化酶模拟物和有效的氧化应激氧化还原调节剂 Mn(III)meso-四(N-乙基吡啶-2-基)卟啉氯化物 MnTE-2-PyP(5+) 的热稳定性。
J Pharm Biomed Anal. 2013 Jan 25;73:29-34. doi: 10.1016/j.jpba.2012.03.033. Epub 2012 Mar 28.
8
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.作为 SOD 模拟物的阳离子 Mn(III) N-取代吡啶卟啉的多种功能。
Free Radic Biol Med. 2011 Sep 1;51(5):1035-53. doi: 10.1016/j.freeradbiomed.2011.04.046. Epub 2011 May 6.
9
Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.超氧化物歧化酶模拟物:化学、药理学和治疗潜力。
Antioxid Redox Signal. 2010 Sep 15;13(6):877-918. doi: 10.1089/ars.2009.2876.
10
High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli.间位锰(III)N-烷基吡啶基卟啉基超氧化物歧化酶模拟物的高亲脂性弥补了它们较低的抗氧化能力,并使其在保护超氧化物歧化酶缺陷型大肠杆菌方面与邻位类似物一样有效。
J Med Chem. 2009 Dec 10;52(23):7868-72. doi: 10.1021/jm900576g.